Es wird erwartet, dass die Miyabi-Angio-Ct-Marktbranche von 4,6 (Milliarden US-Dollar) im Jahr 2024 auf 8,2 (Milliarden US-Dollar) im Jahr 2032 wachsen wird . Die CAGR (Wachstumsrate) des Miyabi Angio...

Se espera que la industria del mercado de Miyabi Angio-Ct crezca de 4,6 (miles de millones de USD) en 2024 a 8,2 (miles de millones de USD) para 2032. Se espera que la CAGR (tasa de crecimiento) del m...

Es wird erwartet, dass die Miyabi-Angio-Ct-Marktbranche von 4,6 (Milliarden US-Dollar) im Jahr 2024 auf 8,2 (Milliarden US-Dollar) im Jahr 2032 wachsen wird . Die CAGR (Wachstumsrate) des Miyabi Angio...

YouTube video by Joe Angio

La principal ventaja de esta técnica diagnóstica es que permite distinguir entre una estenosis anatómica y una estenosis anatómica funcionalmente relevante a partir de la angio-TC cardíaca y ...

Por R$ 79,49

Long-term outcomes of and a risk score model for moderate-risk to high-risk penetrating keratoplasty (see page 981) This study developed a risk score for moderate- to high-risk penetrating keratoplasty based on various risk factors. The risk score can further stratify these grafts into three distinct subgroups: moderate-risk, high-risk, and extremely high-risk. Mitomycin C-based angio-regression for corneal neovascularisation: outcomes with intravascular (MICE), intrastromal (MIST) and combined delivery routes (see page 990) This largest real-world evaluation of MMC intrastromal injection (MIST) and intravascular chemoembolisation (MICE) for refractory corneal vascularisation reports bolld vessel regression in 70% of eyes, rare serious complications, and supports MIST as an accessible angio-regressive strategy. Malignant melanocytic lesions in clinically suspected pterygium (see page 997) Among 2,298 clinically presumed pterygia, 0.30% harboured malignant melanocytic lesions - four invasive melanomas and three high-grade C-MIL. Most melanomas were amelanotic/hypomelanotic,...

Background Corneal neovascularisation (NV) is a refractory condition associated with lipid deposition, scarring and vision loss. Mitomycin C (MMC) intravascular chemoembolisation (MICE) has shown early promise but real-world data remain limited. This study evaluates the efficacy and safety of MICE and MMC intrastromal injection (MIST). Methods Retrospective case series of patients with corneal NV treated with MICE and/or MIST at Moorfields Eye Hospital between March 2023 and March 2025. NV regression was assessed using (1) ImageJ quantitative analysis, (2) masked independent grading of slit-lamp photographs and (3) surgeon-reported outcomes. Corrected distance visual acuity and complications were recorded. Results 39 procedures were performed; median follow-up was 12 months. MIST alone was performed in 70% as intravascular cannulation was achieved in only 15%. NV regression was demonstrated in 59% by ImageJ analysis, 71% by independent grading and 81% by surgeon-reported outcomes. Four patients subsequently underwent successful keratoplasty without NV recurrence. Most complications were mild and self-limiting. Two serious complications involving anterior chamber MMC migration occurred in eyes with significant corneal thinning or prior perforation. Conclusions In the largest cohort reported to date, MICE and MIST represent effective angio-regressive strategies for refractory corneal NV. MIST alone produces meaningful vascular regression, offering a more accessible surgical approach. MMC-based angio-regression appears to be the most effective treatment currently available and may have an important role in stabilising high-risk corneas prior to keratoplasty.

Por R$ 88,07